With regard to COVID‐19, it is known that the angiotensin‐converting enzyme 2 (ACE2) ACE2 provides the cell membrane receptor entry point for SARS‐CoV‐2.2, 3, 4. The gene discussed is ACE2; the disease is COVID-19.